Franz Hefti

Non-Executive Chairman
life sciencess
Alvotech
Andorra

Business Expert Engineering
Biography

 From 2000 to 2008, Dr. Garnier was the first Chief Executive Officer of GlaxoSmithKline, assuming this role upon the merger of SmithKline Beecham and Glaxo Wellcome. Previously, he served as Chief Executive Officer of SmithKline Beecham having joined the company in 1990 as President of Pharmaceuticals for North America. Prior to SmithKline Beecham, Dr. Garnier served as President of Schering-Plough (US). Following his retirement from GlaxoSmithKline, Dr. Garnier was Chief Executive Officer of Pierre Fabre Laboratories and Chairman of Cerenis, a biotechnology company.

Research Intrest

 From 2000 to 2008, Dr. Garnier was the first Chief Executive Officer of GlaxoSmithKline, assuming this role upon the merger of SmithKline Beecham and Glaxo Wellcome. Previously, he served as Chief Executive Officer of SmithKline Beecham having joined the company in 1990 as President of Pharmaceuticals for North America. Prior to SmithKline Beecham, Dr. Garnier served as President of Schering-Plough (US). Following his retirement from GlaxoSmithKline, Dr. Garnier was Chief Executive Officer of Pierre Fabre Laboratories and Chairman of Cerenis, a biotechnology company.

Global Scientific Words in Engineering